Drug Discovery and Development Analysis & Statistics, July 2014 (p30)

Talk to Amrita

+1 718 303 2019

Search inside this page

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

871-910 of about 4 100 reports

Purchase Reports From Reputable Market Research Publishers

Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014

Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ubiquitin Specific Proteases (USP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014

UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“UMP-CMP Kinase (UMP-CMPK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014

Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor A (VEGF-A) Activator-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014

Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
Vasopressin Receptor Agonists -Pipeline Insights, 2014

Vasopressin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Vasopressin Receptor Antagonists -Pipeline Insights, 2014

Vasopressin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014

Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin V1a Receptor (V1aR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Vasopressin V2 Receptor (V2R) Agonists -Pipeline Insights, 2014

Vasopressin V2 Receptor (V2R) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin V2 Receptor (V2R) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vasopressin V2 Receptor (V2R) Antagonists -Pipeline Insights, 2014

Vasopressin V2 Receptor (V2R) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin V2 Receptor (V2R) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Viral Protease Inhibitors -Pipeline Insights, 2014

Viral Protease Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Viral Protease Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Xanthine Oxidase Inhibitors -Pipeline Insights, 2014

Xanthine Oxidase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Xanthine Oxidase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Hypoxia Inducible Factor 1 (HIF-1) Inhibitors -Pipeline Insights, 2014

Hypoxia Inducible Factor 1 (HIF-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hypoxia Inducible Factor 1 (HIF-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Janus Kinase 1 (JAK1) Inhibitors -Pipeline Insights, 2014

Janus Kinase 1 (JAK1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase 1 (JAK1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Janus Kinase 3 (JAK3) Inhibitors -Pipeline Insights, 2014

Janus Kinase 3 (JAK3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase 3 (JAK3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Matrix Metalloproteinase 13 (MMP-13) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 13 (MMP-13) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 13 (MMP-13) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Matrix Metalloproteinase 14 (MMP-14) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 14 (MMP-14) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 14 (MMP-14) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Matrix Metalloproteinase 2 (MMP-2) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 2 (MMP-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 2 (MMP-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Matrix Metalloproteinase 9 (MMP-9) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 9 (MMP-9) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 9 (MMP-9) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Neurokinin 2 (NK2) Receptor Antagonists -Pipeline Insights, 2014

Neurokinin 2 (NK2) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Neurokinin 2 (NK2) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Neurokinin 3 (NK3) Receptor Antagonists -Pipeline Insights, 2014

Neurokinin 3 (NK3) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Neurokinin 3 (NK3) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Retinoid x receptors Beta (RXRs) Agonists -Pipeline Insights, 2014

Retinoid x receptors Beta (RXRs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoid x receptors Beta (RXRs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Retinoid x receptors Gamma (RXRs) Agonists -Pipeline Insights, 2014

Retinoid x receptors Gamma (RXRs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoid x receptors Gamma (RXRs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Sphingosine 1-Phosphate Type 1 (S1P-1) Receptor Agonists -Pipeline Insights, 2014

Sphingosine 1-Phosphate Type 1 (S1P-1) Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Sphingosine 1-Phosphate Type 1 (S1P-1) Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Neuroendocrine Tumors Drug Pipeline Update 2014

Neuroendocrine Tumors Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

There are today 78 companies plus partners developing 86 neuroendocrine tumor drugs in 125 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount ...

  • Industries : Drug Discovery and Development
IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2014

IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

The IL-1 signaling pathway activates the MAPK/JNK signaling modules. The MAPK pathway leads to activation of NFkB complex. As both IL-1 and TNF alpha stimulate the MAPK signaling module and activate NFkB, ...

  • Industries : Drug Discovery and Development
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014

IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

The IL-9 signaling pathway activates Jak/STAT and MAPK signaling modules. There are today 63 companies plus partners developing 67 IL-9 pathway targeting drugs in 275 developmental projects in cancer. ...

  • Industries : Drug Discovery and Development
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014

RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not 'druggable' with small molecules or protein-based therapies. There are today 58 ...

  • Industries : Drug Discovery and Development

About 200 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.